ArticleInternational journal of molecular sciences2017

Systemic Chemokine Levels with "Gut-Specific" Vedolizumab in Patients with Inflammatory Bowel Disease-A Pilot Study.

Stephanie Zwicker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.